Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:26 pm Sale | 13G | ENTRADA THERAPEUTICS INC TRDA | Redmile Group LLC | 1,283,735 3.8% | -570,373 (-30.76%) | View |
| 2024-02-14 4:12 pm Sale | 13G | ENTRADA THERAPEUTICS INC TRDA | ROCHE FINANCE LTD | 2,744,120 8.2% | -69,405 (-2.47%) | View |
| 2024-02-14 10:03 am Sale | 13G | ENTRADA THERAPEUTICS INC TRDA | PRICE T ROWE ASSOCIATES INC | 3,009,673 9% | -4,704 (-0.16%) | View |
| 2023-02-14 4:25 pm Sale | 13G | ENTRADA THERAPEUTICS INC TRDA | Redmile Group LLC | 1,854,108 5.9% | -100,312 (-5.13%) | View |
| 2023-02-14 12:38 pm Purchase | 13G | ENTRADA THERAPEUTICS INC TRDA | PRICE T ROWE ASSOCIATES INC | 3,014,377 9.6% | 993,740 (+49.18%) | View |
| 2023-02-06 2:51 pm Sale | 13G | ENTRADA THERAPEUTICS INC TRDA | WELLINGTON MANAGEMENT GROUP LLP | 1,010,351 3.22% | -2,103,655 (-67.55%) | View |
| 2022-02-14 5:07 pm Purchase | 13G | ENTRADA THERAPEUTICS INC TRDA | Redmile Group LLC | 1,954,420 6.3% | 1,954,420 (New Position) | View |
| 2022-02-14 2:35 pm Purchase | 13G | ENTRADA THERAPEUTICS INC TRDA | PRICE T ROWE ASSOCIATES INC | 2,020,637 6.4% | 2,020,637 (New Position) | View |
| 2022-02-14 06:19 am Purchase | 13G | ENTRADA THERAPEUTICS INC TRDA | ROCHE FINANCE LTD | 2,813,525 9% | 2,813,525 (New Position) | View |
| 2022-02-08 12:03 pm Purchase | 13G | ENTRADA THERAPEUTICS INC TRDA | MRL Ventures Fund LLC | 1,739,768 5.6% | 1,739,768 (New Position) | View |
| 2022-02-04 09:17 am Purchase | 13G | ENTRADA THERAPEUTICS INC TRDA | WELLINGTON MANAGEMENT GROUP LLP | 3,114,006 9.98% | 3,114,006 (New Position) | View |
| 2021-12-16 5:23 pm Unchanged | 13D | ENTRADA THERAPEUTICS INC TRDA | BAKER BROS. ADVISORS LP | 4,704,419 15.1% | 0 (Unchanged) | View |
| 2021-11-12 4:30 pm Purchase | 13D | ENTRADA THERAPEUTICS INC TRDA | 5AM Ventures V L.P. | 4,409,687 14.8% | 4,409,687 (New Position) | View |
| 2021-11-12 4:07 pm Purchase | 13D | ENTRADA THERAPEUTICS INC TRDA | MPM BioVentures 2014 L.P. | 4,427,092 14.8% | 4,427,092 (New Position) | View |
| 2021-11-10 4:50 pm Purchase | 13G | ENTRADA THERAPEUTICS INC TRDA | BAKER BROS. ADVISORS LP | 4,704,419 15.1% | 4,704,419 (New Position) | View |